Oncolytics Biotech (TSE:ONC) Share Price Passes Below 200 Day Moving Average – Time to Sell?

Oncolytics Biotech Inc. (TSE:ONC)’s share price passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of C$14.90 and traded as low as C$14.90. Oncolytics Biotech shares last traded at C$14.90, with a volume of 280 shares changing hands.

Oncolytics Biotech Price Performance

The firm has a market cap of C$1.50 billion, a P/E ratio of -40.27 and a beta of 0.80. The company has a current ratio of 2.88, a quick ratio of 8.86 and a debt-to-equity ratio of 14.58. The business’s fifty day moving average price is C$14.90 and its two-hundred day moving average price is C$14.90.

Oncolytics Biotech Company Profile

Oncolytics Biotech Inc, a clinical-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 clinical trial for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma. It has a co-development agreement with Merck KGaA and Pfizer Inc to co-develop pelareorep, as well as with Roche Holding AG.